Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates Aug 9, 2021 04:02PM
Turning Point Therapeutics Inc. (TPTX) PT Raised to $56 at Canaccord Genuity Sep 5, 2019 06:30AM
Turning Point Therapeutics Inc. (TPTX) PT Raised to $53 at Canaccord Genuity Aug 7, 2019 06:52AM
Turning Point Therapeutics’ CEO to Present at Canaccord Genuity 39th Annual Growth Conference Jul 31, 2019 04:30PM
Turning Point Therapeutics’ CEO to Present at Canaccord Genuity 39th Annual Growth Conference Jul 31, 2019 04:30PM


May 13, 2019 08:51AM Canaccord Genuity Starts Turning Point Therapeutics Inc. (TPTX) at Buy
Apr 22, 2019 04:05PM Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 22, 2019 04:05PM Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 17, 2019 11:55AM Turning Point Therapeutics (TPTX) IPO Opens 35% Higher
Apr 17, 2019 05:53AM Turning Point Therapeutics,Inc. (TPTX) Prices 9.25M Share IPO at $18/Sh
Apr 16, 2019 10:57PM Turning Point Therapeutics Announces Pricing of Initial Public Offering